ALSUntangled 44: curcumin

References

• Available at: http://www.alsuntangled.com/open.php. Accessed January 1, 2018. Archived by WebCite® at: http://www.webcitation.org/6w9UBLg03
   Google Scholar
• Available at: https://en.wikipedia.org/wiki/Curcumin. Accessed January 14, 2018. Archived by WebCite® at: http://www.webcitation.org/6wTGY73ki
   Google Scholar
• Tayyem R, Heath D, Al-Delaimy W, Rock C. Curcumin content of turmeric and curry powders. Nutr Cancer. 2006;55:126–31.
   PubMed Web of Science ®Google Scholar
• Jayaprakasha G, Mohan Rao L, Sakariah K. Improved HPLC method for the determination of curcumin, demethoxycurcumin, and bisdemethoxycurcumin. J Agric Food Chem. 2002;50:3668–72.
   PubMed Web of Science ®Google Scholar
• Nelson K, Dahlin J, Bisson J, Graham J, Pauli G, Walters M. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60:1620–37.
   PubMed Web of Science ®Google Scholar
• Shehzad A, Qureshi M, Anwar M, Lee Y. Multifunctional curcumin mediate multitherapeutic effects. J Food Sci. 2017;82:2006–15.
   PubMed Web of Science ®Google Scholar
• Shen L, Liu L, Hong-Fang J. Regulative effects of curcumin spice administration on gut microbiota and its pharmacological implications. Food Nutr Res. 2017;6:1361780.
   PubMed Web of Science ®Google Scholar
• Zhou H, Beevers C, Huang S. The targets of curcumin. Curr Drug Targets. 2011;12:332–47.
   PubMed Web of Science ®Google Scholar
• Amairaj A, Pius A, Gopi S, Gopi S. Biological activities of curcuminoids, other biomolecules from tumeric and their derivatives: a review. J Tradit Complement Med. 2016;7:205–33.
   PubMedGoogle Scholar
• Patzkó A, Bai Y, Saporta MA, Katona I, Wu X, Vizzuso D, et al. Curcumin derivatives promote Schwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain. 2012;135:3551–66.
   PubMed Web of Science ®Google Scholar
• Heger M. Drug screening: Don't discount all curcumin trial data. Nature. 2017;543:40.
   PubMed Web of Science ®Google Scholar
• Hovden H, Frederiksen J, Pedersen S. Immune system alterations in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica. 2013;128:287–96.
   PubMed Web of Science ®Google Scholar
• Sako W, Ito H, Yoshida M, Koizumi H, Kamada M, Fujita K, et al. Nuclear factor κB expression in patients with sporadic amyotrophic lateral sclerosis and hereditary amyotrophic lateral sclerosis with optineurin mutations. Clin Neuropathol. 2012;31:418–23.
   PubMed Web of Science ®Google Scholar
• Frakes A, Ferraiuolo L, Haidet-Phillips A, Schmelzer L, Braun L, Miranda C, et al. Microglia induce motor neuron death via the classical NF-κB pathway in amyotrophic lateral sclerosis . Neuron. 2014;81:1009–23.
   PubMed Web of Science ®Google Scholar
• Patel P, Julien J, Kriz J. Early-stage treatment with withaferin a reduces levels of misfolded superoxide dismutase 1 and extends lifespan in a mouse model of amyotrophic lateral sclerosis. Neurotherapeutics. 2015;12:217–33.
   PubMed Web of Science ®Google Scholar
• Swarup V, Phaneuf D, Dupre N, Petri S, Strong N, Kriz J, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor κB–mediated pathogenic pathways. J Exp Med. 2011;208:2429–47.
   PubMed Web of Science ®Google Scholar
• Jin C, Lee J, Park C, Choi Y, Kim G. Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacologica Sinica. 2007;28:1645–51.
   PubMed Web of Science ®Google Scholar
• Kang G, Kong P, Yuh Y, Lim S, Yim S, Chun W, et al. Curcumin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression by inhibiting activator protein 1 and nuclear factor B bindings in BV2 microglial cells. J Pharmacol Sci. 2004;94:325–8.
   PubMed Web of Science ®Google Scholar
• Yang S, Zhang D, Yang Z, Hu X, Qian S, et al. Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron/glia culture. Neurochem Res. 2008;33:2044–53.
   PubMed Web of Science ®Google Scholar
• Sharma N, Sharma S, Nehru B. Curcumin protects dopaminergic neurons against inflammation-mediated damage and improves motor dysfunction induced by single intranigral lipopolysaccharide injection. Inflammopharmacol. 2017;25:351–68.
   PubMed Web of Science ®Google Scholar
• Tiwari V, Chopra K. Protective effect of curcumin against chronic alcohol-induced cognitive deficits and neuroinflammation in the adult rat brain. Neuroscience. 2013;244:147–58.
   PubMed Web of Science ®Google Scholar
• Reuter S, Charlet J, Juncker T, Teiten M, Dicato M, Diederich M. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells. Ann N Y Acad Sci. 2009;1171:436–47.
   PubMed Web of Science ®Google Scholar
• Jobin C, Bradham C, Russo M, Juma B, Narula A, Brenner D, et al. Curcumin blocks cytokine-mediated NF-kB activation and proinflammatory gene expression by inhibiting inhibitory factor I-kB kinase activity. J Immunol. 1999;163:3474–83.
   PubMed Web of Science ®Google Scholar
• Schwertheim S, Wein F, Lennartz K, Worm K, Schmid K, Sheu-Grabellus Y. Curcumin induces G2/M arrest, apoptosis, NF-κB inhibition, and expression of differentiation genes in thyroid carcinoma cells. J Cancer Res Clin Oncol. 2017;143:1143–54.
   PubMed Web of Science ®Google Scholar
• Pimentel-Gutiérrez H, Bobadilla-Morales L, Barba-Barba C, Ortega-De-La-Torre C, Sánchez-Zubieta F, Corona-Rivera J, et al. Curcumin potentiates the effect of chemotherapy against acute lymphoblastic leukemia cells via downregulation of NF-κB. Oncol Lett. 2016;12:4117–24.
   PubMed Web of Science ®Google Scholar
• Kanai M, Otsuka Y, Otsuka K, Sato M, Nishimura T, Mori Y, et al. A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin) in cancer patients. Cancer Chemother Pharmacol. 2013;71:1521–30.
   PubMed Web of Science ®Google Scholar
• Bozzo F, Mirra A, Carri M. Oxidative stress and mitochondrial damage in the pathogenesis of ALS: new perspectives. Neurosci Lett. 2017;636:3–8.
   PubMed Web of Science ®Google Scholar
• Blasco H, Garcon G, Patin F, Veyrat-Durebex C, Boyer J, Devos D, et al. Panel of oxidative stress and inflammatory biomarkers in ALS: a pilot study. Can J Neurol Sci. 2017;44:90–5.
   PubMed Web of Science ®Google Scholar
• Ikawa M, Okazawa H, Tsujikawa T, Matsunaga A, Yamamura O, Mori T, et al. Increased oxidative stress is related to disease severity in the ALS motor cortex. Neurology. 2015;84:2033–9.
   PubMed Web of Science ®Google Scholar
• Neymotin A, Calingasan N, Wille E, Naseri N, Petri S, Damiano M, et al. Neuroprotective effect of Nrf2/ARE activators, CDDO ethylamide and CDDO trifluoroethylamide, in a mouse model of amyotrophic lateral sclerosis. Free Rad Biol Med. 2011;51:88–96.
   PubMed Web of Science ®Google Scholar
• Mead R, Higginbottom A, Allen S, Kirby J, Bennet E, Barber S, et al. S[+] Apomorphine is a CNS penetrating activator of the Nrf2-ARE pathway with activity in mouse and patient fibroblast models of amyotrophic lateral sclerosis. Free Rad Biol Med. 2013;61:438–52.
   PubMed Web of Science ®Google Scholar
• Tanaka K, Kanno T, Yanagisawa Y, Yasutake K, Inoue S, Hirayama N, et al. A novel acylaminoimidazole derivative, WN1316, alleviates disease progression via suppression of glial inflammation in ALS mouse model. PLoS One. 2014;9:e87728.
   PubMed Web of Science ®Google Scholar
• Ak T, Gulcin A. Antioxidant and radical scavenging properties of curcumin. Chem Biolo Interact. 2008;174:27–37.
   PubMed Web of Science ®Google Scholar
• Cui Q, Li X, Zhu H. Curcumin ameliorates dopaminergic neuronal oxidative damage via activation of the Akt/Nrf2 pathway. Mol Med Rep. 2016;13:1381.
   PubMed Web of Science ®Google Scholar
• Li W, Suwanwela N, Patumraj S. Curcumin by down-regulating NF-kB and elevating Nrf2, reduces brain edema and neurological dysfunction after cerebral I/R. Microvasc Res. 2016;106:117–27.
   PubMed Web of Science ®Google Scholar
• Wu J, Li Q, Wang X, Yu S, Li L, Wu X, et al. Neuroprotection by curcumin in ischemic brain injury involves the Akt/Nrf2 pathway. PLoS One. 2013;8:e59843.
   PubMed Web of Science ®Google Scholar
• He H, Wang G, Gao Y, Ling W, Yu Z, Jin T. Curcumin attenuates Nrf2 signaling defect, oxidative stress in muscle and glucose intolerance in high fat diet-fed mice. World J Diabetes. 2012;3:94–104.
   PubMedGoogle Scholar
• Sahin K, Pala R, Tuzcu M, Ozdemir O, Orhan C, Sahin N, et al. Curcumin prevents muscle damage by regulating NF-kB and Nrf2 pathways and improves performance: an in vivo model. J Inflamm Res. 2016;9:147–54.
   PubMed Web of Science ®Google Scholar
• Jiang H, Tian X, Guo Y, Duan W, Bu H, Li C. Activation of nuclear factor erythroid 2-related cytoprotective signaling by curcumin protect primary spinal cord astrocytes against oxidative toxicity. Biol Pharm Bull. 2011;34:1194–7.
   PubMed Web of Science ®Google Scholar
• Nazari QA, Takada-Takatori Y, Hashimoto T, Imaizumi A, Izumi Y, Kume T. Potential protective effect of highly bioavailable curcumin on an oxidative stress model induced by microinjection of sodium nitroprusside in mice brain. Food Func. 2014;5:984–9.
   PubMed Web of Science ®Google Scholar
• Pungcharoenkul K, Thongnopnua P. Effect of different curcuminoid supplement dosages on total in vivo antioxidant capacity and cholesterol levels of healthy human subjects. Phytother Res. 2011;25:1721–6.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, et al. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res. 2013;27:1883–8.
   PubMed Web of Science ®Google Scholar
• Kalpravidh R, Siritanaratkul N, Insain P, Charoensakdi R, Panichkul N, Hatairaktham S, et al. Improvement in oxidative stress and antioxidant parameters in β-thalassemia/Hb E patients treated with curcuminoids. Clin Biochem. 2010;43:424–9.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Suzuki K, Kim H, Otsuka Y, Imaizumi A, Miyashita M, et al. Effects of curcumin supplementation on exercise-induced oxidative stress in humans. Int J Sports Med. 2014;35:469–75.
   PubMed Web of Science ®Google Scholar
• Usharani P, Mateen A, Naidu M, Raju Y, Chandra N. Effect of NCB-02, atorvasatin, and placebo on endothelial function, oxidative stress, and inflammatory markers in patients with type 2 diabetes mellitus. Drugs RD . 2008;9:243–50.
   PubMed Web of Science ®Google Scholar
• Panahi P, Ghanei M, Hajhashemi A, Sahebkar A. Effects of curcuminoids-piperine combination on systemic oxidative stress, clinical symptoms and quality of life in subjects with chronic pulmonary complications due to sulfur mustard: a randomized controlled trial. J Diet Suppl. 2016;13:93–105.
   PubMedGoogle Scholar
• Panahi Y, Alishiri G, Parvin S, Sahebkar A. Mitigation of systemic oxidative stress by curcuminoids in osteoarthritis: results of a randomized controlled trial. J Diet Suppl. 2016;13:209–20.
   PubMedGoogle Scholar
• Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian M, Majeed M, et al. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacol. 2017;25:25–31.
   PubMed Web of Science ®Google Scholar
• Panahi Y, Hosseini M, Khalili N, Naimi E, Majeed M, Sahebkar A. Antioxidant and anti-inflammatory effects of curcuminoid-piperine combination in subjects with metabolic syndrome: a randomized controlled trial and an updated meta-analysis. Clin Nutr. 2015;34:1101–8.
   PubMed Web of Science ®Google Scholar
• Hejazia J, Rastmaneshb R, Taleban FA, Molana SH, Hejazi E, Ehtejab G, et al. Effect of curcumin supplementation during radiotherapy on oxidative status of patients with prostate cancer: a double blinded, randomized, placebo-controlled study. Nutr Cancer. 2016;68:77–85.
   PubMed Web of Science ®Google Scholar
• Yang H, Xu W, Zhou Z, Liu J, Li X, Chen L, et al. Curcumin attenuates urinary excretion of albumin in type II diabetic patients with enhancing nuclear factor erythroid-derived 2-like 2 (Nrf2) system and repressing inflammatory signaling efficacies. Exp Clin Endocrinol Diabetes. 2015;123:360–7.
   PubMed Web of Science ®Google Scholar
• Parakh S, Atkin J. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633–49.
   PubMed Web of Science ®Google Scholar
• Kieran D, Kalmar B, Dick J, Riddoch-Contreras J, Burnstock G, Greensmith L. Treatment with arimoclomol, a coinducer of heat shock proteins, delays progression in ALS mice. Nat Med. 2004;10:402–5.
   PubMed Web of Science ®Google Scholar
• Curcumin binds to the pre-fibrillar aggregates of Cu/Zn superoxide dismutase (SOD1) and alters its amyloidogenic pathway resulting in reduced cytotoxicity. Biochim Biophys Acta. 2015;1854:426–36.
   PubMed Web of Science ®Google Scholar
• Cashman J, Gagliardi S, Lanier M, Ghirmai S, Abel K, Fiala M. Curcumins promote monocytic gene expression related to beta-amyloid and superoxide dismutase clearance. Neurodegenerative Dis. 2012;10:274–6.
   PubMed Web of Science ®Google Scholar
• Longstreth J, Meschke J, Davidson S, Smoot L, Koepsell T. Hypothesis: a motor toxin produced by a clostridial species residing the gut causes ALS. Med Hypotheses. 2005;64:1153.
   PubMed Web of Science ®Google Scholar
• Rowin J, Xia Y, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiol Rep. 2017;5:e13443.
   PubMed Web of Science ®Google Scholar
• Mazzini L, Mogna L, Marchi FD, Amoruso A, Pane M, Aloiso I, et al. Potential role of gut microbiota in ALS pathogenesis. Amyotroph Lateral Scler and Frontotemporal Degenr. 2017;18:245.
   PubMedGoogle Scholar
• Brenner D, Hiergeist A, Adis C, Mayer B, Gessner A, Ludolph A, et al. The fecal microbiome of ALS patients. Neurobiol Aging. 2018;61:132–7.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wu S, Yi J, Xia Y, Jin D, Zhou J, et al. Target intestinal microbiota to alleviate disease progression in amyotrophic lateral sclerosis. Clin Ther. 2017;39:322–36.
   PubMed Web of Science ®Google Scholar
• Labarre A, Guitard E, Parker J. Variation of gut microbiome rescues paralysis and neurodegeneration profiles in C. elegans ALS models. Amyotroph Lateral Scler and Frontotemporal Degenr. 2017;18:245–6.
   PubMedGoogle Scholar
• Ohno M, Nishida A, Sugitani Y, Nishino K, Inatomi O, Sugimoto M et al. Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells. PLoS One. 2017;12:e0185999.
   PubMed Web of Science ®Google Scholar
• Dong H, Xu L, Wu L, Wang X, Duan W, Li H, et al. Curcumin abolishes mutant TDP-43 induced excitability in a motoneuron-like cellular model of ALS. Neuroscience. 2014;272:141–53.
   PubMed Web of Science ®Google Scholar
• Lu J, Duan W, Guo Y, Jiang H, Li Z, Huang J, et al. Mitochondrial dysfunction in human TDP-43 transfected NSC34 cell lines and the protective effect of dimethoxy curcumin. Brain Res Bull. 2012;89:185–90.
   PubMed Web of Science ®Google Scholar
• Duan W, Guo Y, Xiao J, Chen X, Li Z, Han H, et al. Neuroprotection by monocarbonyl dimethoxycurcumin C: ameliorating the toxicity of mutant TDP-43 via HO-1. Mol Neurobiol. 2014;49:368–79.
   PubMed Web of Science ®Google Scholar
• Available at: https://www.patientslikeme.com/treatments/show/532. Accessed: January 8, 2018. Archived by WebCite® at: http://www.webcitation.org/6wJwJcnpN
   Google Scholar
• Harrison D, Bedlack R. ALS reversals: demographics, disease characteristics, treatments and co-morbidities. Presented at American Academy of Neurology April 25, 2017.
   Google Scholar
• Ahmadi M, Elmira A, Nafissi S, Jaafari MR, Harirchian MH, Sarraf P, et al. Safety and efficacy of nanocurcumin as add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a pilot randomized clinical trial. Neurotherapeutics. 2018. [Epub ahead of print]. DOI: 10.1007/s13311-018-0606-7
   PubMed Web of Science ®Google Scholar
• Lo Gerfo A, Caldarazzo I, Petrozzi L, Rocchi A, Modena M, Pasquinelli A, et al. Amyotrophic lateral sclerosis and oxidative stress: a double blind trial after dietary supplement by a curcumin donor. Presented at 2nd Congress of European Academy of Neurology May 28–31, 2016.
   Google Scholar
• Qin S, Huang L, Gong J, Shen S, Huang J, Ren H, et al. Efficacy and safety of turmeric and curcumin in lowering blood lipid levels in patients with cardiovascular risk factors: a meta-analysis of randomized controlled trials. Nutr J. 2017;16:68.
   PubMed Web of Science ®Google Scholar
• Sahebkar A, Henrotin Y. Analgesic efficacy and safety of curcuminoids in clinical practice: a systematic review and meta-analysis of randomized controlled trials. Pain Med. 2016;17:1192–202.
   PubMed Web of Science ®Google Scholar
• Al-Karawi D, Al Mamoori D, Tayyar Y. The role of curcumin administration in patients with major depressive disorder: mini meta-analysis of clinical trials. Phytother Res. 2016;30:175–83.
   PubMed Web of Science ®Google Scholar
• Available at: https://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/PharmacyCompounding/ucm570192.htm. Accessed: January 14, 2018. Archived by WebCite® at: http://www.webcitation.org/6wTFyQ5bh
   Google Scholar
• Bahramsoltani R, Rahimi R, Farzaei MH. Pharmacokinetic interactions of curcuminoids with conventional drugs: a review. J Ethnopharmacol. 2017;209:1–12.
   PubMed Web of Science ®Google Scholar
• Kusuhara H, Furuie H, Inano A, Sunagawa A, Yamada S, Wu C, et al. Pharmacokinetic interaction study of sulphasalazine in healthy subjects and the impact of curcumin as an in vivo inhibitor of BCRP. Brit J Pharmacol.2012;166:1793–803.
   PubMed Web of Science ®Google Scholar
• Chen Y, Liu WH, Chen BL, Fan L, Han Y, Wang G, et al. Plant polyphenol curcumin significantly affects CYP1A2 and CYP2A6 activity in healthy, male chinese volunteers. Ann Pharmacother. 2010;44:1038–45.
   PubMed Web of Science ®Google Scholar
• Juan H, Terhaag B, Cong Z, Bi-Kui Z, Rong-Hua Z, et al. Unexpected effect of concomitantly administered curcumin on the pharmacokinetics of talinolol in healthy Chinese volunteers. Eur J Clin Pharmacol. 2007;63:663–8.
   PubMed Web of Science ®Google Scholar
• Mahran RI, Hagras MM, Sun D, Brenner DE. Bringing curcumin to the clinic in cancer prevention: a review of strategies to enhance bioavailability and efficacy. AAPS J. 2017;19:54–81.
   PubMed Web of Science ®Google Scholar
• Kanai M, Imaizumi A, Otsuka Y, Sasaki H, Hasiguchi M, Tsujiko K, et al. Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy volunteers. Cancer Chemother Pharmacol. 2012;69:65–70.
   PubMed Web of Science ®Google Scholar
• Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamato M, Okamura N, et al. Colloidal submicron particle curcumin exhibits high absorption efficiency-a double blind, 3 way crossover study. J Nutr Sci Vitaminol. 2015;61:37–44.
   PubMed Web of Science ®Google Scholar
• Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011;74:664–9.
   PubMed Web of Science ®Google Scholar
• Available from: http://dolcas-biotech.com/products/bcm95/. Accessed: January 15, 2018. Archived by WebCite® at: http://www.webcitation.org/6wV3tc5py
   Google Scholar
• Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinvas P. Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Med. 1998;64:353–6.
   PubMed Web of Science ®Google Scholar
• Small G, Siddarth P, Zhaoping L, Miller K, Ercoli L, Emerson N, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry. 2017;17:S1064.
   Google Scholar
• Available at: http://www.integrativepro.com/Products/Metabolic/Theracurmin-HP. Accessed January 15, 2018. Archived by WebCite® at: http://www.webcitation.org/6wUXG11HH
   Google Scholar